Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-27 Sale |
2023-02-28 5:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
354 | $287.48 | $101,768 | 56,805 (Direct) |
View |
| 2023-02-27 Sale |
2023-02-28 4:47 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
5,034 | $287.47 | $1,447,143 | 56,696 (Indirect Direct) |
View |
| 2023-02-27 Sale |
2023-02-28 4:44 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
1,207 | $287.55 | $347,072 | 7,303 (Direct) |
View |
| 2023-02-27 Sale |
2023-02-28 4:40 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,238 | $287.51 | $1,218,449 | 32,038 (Direct) |
View |
| 2023-02-22 Sale |
2023-02-24 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
2,401 | $294.33 | $706,679 | 66,444 (Indirect Direct) |
View |
| 2023-02-21 Sale |
2023-02-22 4:48 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
480 | $293.75 | $141,002 | 60,467 (Direct) |
View |
| 2023-02-21 Sale |
2023-02-22 4:30 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
2,402 | $293.75 | $705,596 | 68,845 (Indirect Direct) |
View |
| 2023-02-21 Sale |
2023-02-22 4:25 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,002 | $293.77 | $1,175,676 | 40,246 (Direct) |
View |
| 2023-02-14 Sale |
2023-02-16 4:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
320 | $298.52 | $95,527 | 65,445 (Direct) |
View |
| 2023-02-14 Sale |
2023-02-16 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
2,181 | $300.39 | $655,161 | 59,734 (Direct) |
View |
| 2023-02-14 Sale |
2023-02-16 4:14 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
6,398 | $298.68 | $1,910,962 | 75,745 (Indirect Direct) |
View |
| 2023-02-14 Sale |
2023-02-16 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
6,398 | $298.7 | $1,911,108 | 47,998 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-14 5:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
275 | $298.99 | $82,223 | 65,765 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-14 5:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
113 | $300.39 | $33,944 | 61,915 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-14 4:53 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,887 | $298.92 | $1,460,816 | 82,143 (Indirect Direct) |
View |
| 2023-02-13 Sale |
2023-02-14 4:49 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,798 | $298.9 | $1,434,126 | 54,396 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 4:53 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $306 | $399,022 | 68,645 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-24 Tax Withholding |
2023-02-28 5:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,308 | $289.12 | 58,133 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 5:11 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
3,308 | $289.12 | 56,805 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 5:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
3,970 | $289.12 | 52,014 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 5:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
2,468 | $289.12 | 76,261 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 4:57 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
13,730 | $289.12 | 48,789 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
9,386 | $289.12 | 129,969 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
3,308 | $289.12 | 63,207 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 4:47 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,714 | $289.12 | 56,696 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 4:44 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
502 | $289.12 | 7,303 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 4:40 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,970 | $289.12 | 32,038 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,750 | $292.85 | 61,441 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,498 | $292.85 | 60,467 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
3,750 | $292.85 | 55,984 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
3,498 | $292.85 | 78,729 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:35 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
9,359 | $292.85 | 139,355 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:32 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
3,750 | $292.85 | 66,515 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:30 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,498 | $292.85 | 68,845 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:25 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,750 | $292.85 | 40,246 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 5:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
2,707 | $294.33 | 65,191 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 5:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
4,992 | $298.26 | 65,191 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 5:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
1,377 | $294.33 | 65,765 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 5:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,995 | $298.26 | 65,765 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 5:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
902 | $294.33 | 61,915 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 5:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
4,340 | $298.26 | 61,915 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 5:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
2,611 | $294.33 | 82,227 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 5:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
4,657 | $298.26 | 82,227 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 5:01 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
13,344 | $298.26 | 62,519 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 4:58 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
3,372 | $294.33 | 148,714 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 4:58 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
5,990 | $298.26 | 148,714 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 4:55 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,707 | $294.33 | 70,265 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 4:55 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
4,992 | $298.26 | 70,265 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,372 | $294.33 | 82,143 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
5,990 | $298.26 | 82,143 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 4:49 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,461 | $294.33 | 54,396 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 4:49 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
5,990 | $298.26 | 54,396 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $187.53 | 68,645 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:53 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $0 | 68,645 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:03 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
30,026 | $0 | 72,890 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:01 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
24,322 | $0 | 70,412 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:58 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
29,272 | $0 | 67,270 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:56 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
26,400 | $0 | 100,547 (Direct) |
View |
| 2022-05-17 Gift |
2023-02-03 4:56 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
1,672 | $0 | 100,547 (Indirect) |
View |
| 2023-02-02 Tax Withholding |
2023-02-03 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
3,578 | $317.83 | 75,863 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
76,578 | $0 | 75,863 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
68,478 | $0 | 158,076 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:44 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
28,452 | $0 | 77,964 (Direct) |
View |